Advancement in the research on vascular endothelial growth inhibitor (VEGI)

Targeted Oncology

Volumn 7, Issue 1, 2012, Pages 87-90

  Duan, Lijiao ^a,b   Yang, Ganggang ^a,b   Zhang, Ruigang ^a,b   Feng, Lijuan ^a,b   Xu, Cunshuan ^a,b  

^a HENAN NORMAL UNIVERSITY   (China)

^b Key Laboratory for Cell Differentiation and Regulation   (China)

Author keywords

Angiogenesis; Apoptosis; Solid tumor; Vascular endothelial growth inhibitor

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECOMBINANT HUMAN VASCULAR ENDOTHELIAL GROWTH INHIBITOR; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR 251; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER RECURRENCE; DRUG SPECIFICITY; ENDOTHELIUM CELL; GENETIC ENGINEERING; GROWTH INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOLID TUMOR; SURVIVAL TIME; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; ENDOTHELIAL CELLS; GENETIC ENGINEERING; GROWTH INHIBITORS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84860736721     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-012-0206-0     Document Type: Review

References (27)

1. Tan KB, Harrop J, Reddy M et al (1997) Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 204(1-2):35-46. doi:10.1016/S0378-1119(97)00509-X (Pubitemid 28022168)
2. Zhai Y, Ni J, Jiang GWet al (1999) VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J 13:181-189 (Pubitemid 29038287)
3. Zhai Y, Yu J, Iruela-Arispe L et al (1999) Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily. Int J Cancer 82:131-136. doi:10.1002/(SICI)1097-0215 (Pubitemid 29266118)
4. Chew LJ, Pan H, Yu J et al (2002) A novel secreted splice variant of vascular endothelial cell growth inhibitor. FASEB J 16:742-744. doi:10.1096/fj.01-0757fje
5. Yu J, Tian S, Metheny-Barlow L et al (2001) Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor. Circ Res 89:1161-1167. doi:10.1161/ hh2401.101909 (Pubitemid 34627874)
6. Zhang M, Wang L, Wang HW et al (2003) The impact of the deletion of N-terminus of VEGI on its bioactivity. Acta Bioch Bioph Sin 35(2):33-137
7. Zhang N, Sanders AJ, Ye L et al (2009) Vascular endothelial growth inhibitor in human cancer. Int J Mol Med 24:3-8. doi:10.3892/ijmm-00000198
8. Sethi G, Sung B, Aggarwal BB (2009) Therapeutic potential of VEGI/TL1A in autoimmunity and cancer. Adv Exp Med Biol 647:207-215. doi:10.1007/978-0-387- 89520-8-15
9. Yang CR, Hsieh SL, Teng CM et al (2004) Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action. Cancer Res 64:1122-1129. doi:10.1158/0008- 5472.CAN-03-0609
10. Xiao Q, Hsu CY, Chen H et al (2005) Characterization of cisregulatory elements of the vascular endothelial growth inhibitor gene promoter. Biochem J 388:913-920. doi:10.1042/BJ20041739 (Pubitemid 40941579)
11. Huang S, Robinson JB, Deguzman A et al (2000) Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60:5334-5339
12. Udalova IA, Richardson A, Denys A et al (2000) Functional consequences of a polymorphism affecting NF-kappaB p50- p50 binding to the TNF promoter region. Mol Cell Biol 20:9113-9119 (Pubitemid 32246100)
13. Sammy G, Tian F, Li LY (2009) Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-κB pathway. Apoptosis 14:788-795. doi:10.1007/s10495-009-0351-9
14. Yue TL, Ni J, Romanic AM et al (1999) TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stressactivated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. J Biol Chem 274:1479-1486. doi:10.1074/jbc.274.3.1479 (Pubitemid 29057967)
15. Chen CX, Zhuang GH (2006) The progress in researches on VEGI. Chin J Cancer Biother 13(4):308-310 [Article in Chinese]
16. Parr C, Gan CH, Watkins G et al (2006) Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients. Angiogenesis 9:73-81. doi:10.1007/s10456-006-9033-1 (Pubitemid 44440552)
17. Haridas V, Shrivastava A, Su J et al (1999) VEGI, a new member of the TNF family activates nuclear factor-kappaB and c-Jun Nterminal kinase and modulates cell growth. Oncogene 18:6496-6504
18. Zhang N, Sanders AJ, Ye L et al (2010) Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro. Anticancer Res 30:87-95
19. Zhang N, Sanders AJ, Ye L et al (2009) Vascular endothelial growth inhibitor, expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitro. Int J Oncol 35:1473-1480. doi:10.3892/ijo-00000466
20. Tian F, Liang PH, Li LY (2009) Inhibition of endothelial progenitor cell differentiation by VEGI. Blood 113:5352-5360. doi:10.1182/blood-2008-08-173773
21. Liang PH, Tian F, Lu Y et al (2010) Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors. Angiogenesis 14(1):61-68. doi:10.1007/s10456-010- 9195-8
22. Lou YH, Jiao BH, Xiao Yet al (2002) Recombinant human soluble VEGI expresses efficiently in E. coli. Acad J Sec Mil Med Univ 23 (2):140-142 [Article in Chinese]
23. Chen X, Wu J, Liu H et al (2010) Approaches to efficient production of recombinant angiogenesis inhibitor rhVEGI-192 and characterization of its structure and antiangiogenic function. Protein Sci 19:449-457. doi:10.1002/pro.323
24. Cai JP,Wei RL, Cheng JW (2008) Preparation and characterization of a novel chimeric protein VEGI-CTT in Escherichia coli. J Biomed Biotechnol 10:1-9. doi:10. 1155/2008/564969
25. Liu L, Chen YG, Tan LS et al (2001) Secretory expression of human VEGI in Pichia pastoris. Lett Biotechnol 12(2):85-87
26. Xiao T, Fan JK, Huang HL et al (2010) VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis. Cell Res 20:367-378. doi:10.1038/cr.2009.126
27. Li Z, Pan X, Pan W et al (2003) Packaging and identification of recombinant adenovirus vector carrying hENDO-sVEGI. Shijie Huaren Xiaohua Zazhi 11(6):741-744